Blue Willow Systems brings wearables to seniors

The danger of falling for a senior is a real threat, especially for those who are alone for extended periods of time. Blue Willow Systems is changing the way older individuals are monitored with wearable technology that improves patient monitoring.

After experiencing the loss of his father after he had fallen and gone undetected, Blue Willow Systems Founder and CEO Vikram Devdas developed new ways to monitor seniors 24/7 to reduce such incidents. Blue Willow Systems brings together wearable technology, patient monitoring and cloud sharing to provide care to these elderly patient at a low cost.

Blue Willow System uses wearable and sensors in the senior's living space. Information is constantly being sent to mobile and computers for the review of caregivers and when a threat is detected the system send an alert to notify caregiver immediately of an accident. The system is able to collect data on each patient and report on patient trends and risks, this information can be shared through the systems cloud sharing. The cloud technology allows for caregivers to monitor their patients in multiple locations and on-the go. Blue Willow was made as a software-as-a-service, making it cost effective because you are only paying for the functions that you use.

"Previous technologies required the wearer to pull a string," said Devdas. "What if your mother has a stroke and is incapacitated? Or your grandfather has a heart attack and is unable to move? The automatic features of geo-sensing in the Blue Willow device make previous technologies obsolete."

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Trimed Popup
Trimed Popup